Development of a fully canine anti-canine CTLA4 monoclonal antibody for comparative translational research in dogs with spontaneous tumors

The immune checkpoint inhibitor (ICI) ipilimumab has revolutionized the treatment of patients with different cancer histologies, including melanoma, renal cell carcinoma, and non-small cell lung carcinoma. However, only a subset of patients shows dramatic clinical responses to treatment. Despite int...

Descripción completa

Detalles Bibliográficos
Autores principales: Mason, Nicola J., Chester, Nicholas, Xiong, Ailian, Rotolo, Antonia, Wu, Ying, Yoshimoto, Sho, Glassman, Patrick, Gulendran, Gayathri, Siegel, Don L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726733/
https://www.ncbi.nlm.nih.gov/pubmed/34856888
http://dx.doi.org/10.1080/19420862.2021.2004638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726733/
https://www.ncbi.nlm.nih.gov/pubmed/34856888
http://dx.doi.org/10.1080/19420862.2021.2004638

Ejemplares similares